Drug & Medication Database

skin protect

Brands: Reorganic Eyelash Growth Boosting Serum

11 DESCRIPTION The active ingredient in pantoprazole sodium delayed-release tablets, USP, a PPI, is a substituted benzimidazole, 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl] sulfinyl]benzimidazole, sodium salt, sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S . 1.5 H 2 O, with a molecular weight of 432.4. The structural formula is: Pantoprazole sodium sesquihydrate, USP is a white to off-white powder.

Brands: Pantoprazole Sodium

Dosage form: POWDER. Active ingredients: PANTOPRAZOLE MAGNESIUM (25 kg/25kg). Category: BULK INGREDIENT.

11 DESCRIPTION The active ingredient in pantoprazole sodium delayed-release tablets USP, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl] -1 H -benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S x 1.5 H 2 O, with a molecular weight of 432.4.

Brands: Pantoprazole Sodium

11 DESCRIPTION The active ingredient in pantoprazole sodium delayed-release tablets, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S x 1.5 H 2 O, with a molecular weight of 432.37. The structural formula is: Pantoprazole sodium is a white to off-white powder and is racemic.

Brands: Pantoprazole Sodium Delayed-release

The active ingredient in Pantoprazole Sodium Delayed-Release Tablets, USP, a PPI, is a substituted benzimidazole, 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl] sulfinyl]benzimidazole, sodium salt, sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16H 14F 2N 3NaO 4S . 1.5 H 2O, with a molecular weight of 432.4. The structural formula is: Pantoprazole sodium sesquihydrate, USP is a white to off-white powder.

Brands: Pantoprazole Sodium Dr

11 DESCRIPTION The active ingredient in pantoprazole sodium for delayed-release oral suspension, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S x 1.5 H 2 O, with a molecular weight of 432.37.

Brands: Pantoprazole Sodium Delayed-release Delayed Release

11 DESCRIPTION The active ingredient in pantoprazole sodium in 0.9% sodium chloride injection, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C16H14F2N3NaO4S, with a molecular weight of 405.4. The structural formula is: Pantoprazole sodium is a white to off-white crystalline powder and is racemic.

Brands: Pantoprazole Sodium

11 DESCRIPTION The active ingredient in pantoprazole sodium for injection (pantoprazole sodium), a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S, with a molecular weight of 405.4. The structural formula is: Pantoprazole sodium is a white or almost white powder and is racemic.

Brands: Pantoprazole Sodium

Dosage form: POWDER. Active ingredients: PANTOPRAZOLE SODIUM (50 kg/50kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: PANTOPRAZOLE SODIUM (50 kg/50kg). Category: BULK INGREDIENT.

Manufactured by HOSPIRA. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: ASCORBIC ACID (N/A,80MG/VIAL); BIOTIN (N/A,0.02MG/VIAL); CYANOCOBALAMIN (N/A,0.001MG/VIAL); ERGOCALCIFEROL (400 IU/10ML,N/A); FOLIC ACID (N/A,0.14MG/VIAL); NIACINAMIDE (N/A,17MG/VIAL); PANTOTHENIC ACID (N/A,5MG/VIAL); PHYTONADIONE (0.2MG/10ML,N/A); PYRIDOXINE (N/A,1MG/VIAL); RIBOFLAVIN (N/A,1.4MG/VIAL); THIAMINE (N/A,1.2MG/VIAL); VITAMIN A PALMITATE (EQ 2,300 UNITS BASE/10ML,N/A); VITAMIN E (7 IU/10ML,N/A). A

Dosage form: POWDER. Active ingredients: PAPAVERINE HYDROCHLORIDE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

DESCRIPTION Papaverine Hydrochloride, USP, is the hydrochloride of an alkaloid obtained from opium or prepared synthetically. It belongs to the benzylisoquinoline group of alkaloids. It does not contain a phenanthrene group as do morphine and codeine. Papaverine Hydrochloride, USP, is 6,7-dimethoxy-1- veratrylisoquinoline hydrochloride and contains, on the dried basis, not less than 98.5% of C 20 H 21 NO 4 •HCl. The molecular weight is 375.85. The structural formula is as shown.

Brands: Papaverine Hydrochloride

For Facial Skin Moisturizing, Antioxidant, Blemish Removal, Whitening, Brightening

Brands: Papaya Gluta Facecream

For skin cleansing, exfoliation，Nourish and Whitening

Brands: Papaya Glutasoap

For relief of sinus congestion and rhinitis. Application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. With severe forms of this disease, a clinically proven therapy is indicated.

Brands: Ricura

Dosage form: POWDER. Active ingredients: AMINOHIPPURIC ACID (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ACETAMINOPHEN (.96 kg/kg). Category: DRUG FOR FURTHER PROCESSING.

Dosage form: POWDER. Active ingredients: ACETAMINOPHEN (1 kg/kg). Category: BULK INGREDIENT.

Purpose Antimicrobial

Brands: Ameriwash

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: SUMMER FLOUNDER (.1 g/mL). Category: BLA.

Brands: Flounder

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: ATLANTIC COD (.1 g/mL); ATLANTIC HALIBUT (.1 g/mL); SUMMER FLOUNDER (.1 g/mL). Category: BLA.

Brands: Mixed Fish

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: SOUTHERN FLOUNDER (.05 g/mL). Category: BLA.

Brands: Flounder

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: RED KING CRAB (.1 g/mL). Category: BLA.

Brands: Crab

Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: AMERICAN LOBSTER (.1 g/mL); COMMON SHRIMP (.1 g/mL); EASTERN OYSTER (.1 g/mL); RED KING CRAB (.1 g/mL). Category: BLA.

Brands: Mixed Shellfish

Manufactured by ABBVIE. Dosage form: CAPSULE. Route: ORAL. Active ingredients: PARAMETHADIONE (300MG). Application: NDA006800.

Manufactured by LILLY. Dosage form: TABLET. Route: ORAL. Active ingredients: PARAMETHASONE ACETATE (1MG). Application: NDA012772.

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Parasite Nosode Combination 9405

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Parasites/amoeba/protozoan Nosode Combination 9402